Cancer Communications
indexed by SCI
BMC

doi: 10.5732/cjc.011.10367
Application of mesenchymal stem cells as a vehicle to deliver replication-competent adenovirus for treating malignant glioma
Cui Hai, Yong-Min Jin, Wen-Biao Jin, Zhe-Zhu Han, Mei-Nv Cui, Xue-Zhe Piao, Xiong-Hu Shen, Song-Nan Zhang, Hong-Hua Sun
Department of Oncology, Affiliated Hospital of Yanbian University, Yanji, Jilin 133000, P.R. China
[Abstract] Although gene therapy was regarded as a promising approach for glioma treatment, its therapeutic efficacy was often disappointing because of the lack of efficient drug delivery systems. Mesenchymal stem cells(MSCs) have been reported to have a tropism for brain tumors and thus could be used as delivery vehicles for glioma therapy. Therefore, in this study, we attempted to treat glioma by using MSCs as a vehicle for delivering replication-competent adenovirus. We firstly compared the infectivity of type 3, type 5, and type 35 fiber-modified adenoviruses in MSCs. We also determined suitable adenovirus titer in vitro and then used this titer to analyze the ability of MSCs to deliver replication-competent adenovirus into glioma in vivo. Our results indicated that type 35 fiber-modified adenovirus showed higher infectivity than did naked type 3 or type 5 fiber-modified adenovirus. MSCs carrying replication-competent adenovirus significantly inhibited tumor growth in vivo compared with other control groups. In conclusion, MSCs are an effective vehicle that can successfully transport replication-competent adenovirus into glioma, making it a potential therapeutic strategy for treating malignant glioma.
Chinese Journal of Cancer 2012, Volume: 31, Issue 5, Page: 233-240
[ PDF Full-text ]
[ Html full-text ](PubMed Central)

[ PubMed ]

[Google Scholar]


Cite this article

Cui Hai, Yong-Min Jin, Wen-Biao Jin, Zhe-Zhu Han, Mei-Nv Cui, Xue-Zhe Piao, Xiong-Hu Shen, Song-Nan Zhang, Hong-Hua Sun. Application of mesenchymal stem cells as a vehicle to deliver replication-competent adenovirus for treating malignant glioma. Chin J Cancer. 2012, 31(5):233-240. doi:10.5732/cjc.011.10367


Export citations

EndNote


SHARE THIS ARTICLE


Your Comments

  

 


Comments:


CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China